PharmaCielo Ltd. (PCLO.V)
- Previous Close
0.0500 - Open
0.0500 - Bid 0.0450 x --
- Ask 0.0550 x --
- Day's Range
0.0500 - 0.0525 - 52 Week Range
0.0250 - 0.2600 - Volume
31,000 - Avg. Volume
194,675 - Market Cap (intraday)
9.1M - Beta (5Y Monthly) 1.87
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date Jun 30, 2025 - Jul 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with Benuvia Operations, LLC to produce cGMP pharmaceutical-grade CBD active pharmaceutical ingredients. PharmaCielo Ltd. is headquartered in Toronto, Canada.
www.pharmacielo.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PCLO.V
View MorePerformance Overview: PCLO.V
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PCLO.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PCLO.V
View MoreValuation Measures
Market Cap
9.10M
Enterprise Value
29.48M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.46
Price/Book (mrq)
--
Enterprise Value/Revenue
8.47
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-262.70%
Return on Assets (ttm)
-14.33%
Return on Equity (ttm)
--
Revenue (ttm)
3.48M
Net Income Avi to Common (ttm)
-9.14M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
147.94k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.45M